Efficiency Of Anlotinib Hydrochloride As 3rd Line Treatment In Patients (Pts) From A Randomized, Double-Blind, Placebo-Controlled Phase Iii Trial, An Exploratory Subgroup Analysis Of Alter0303 Trial For The Previous Therapy Strategy Effect